Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kala Bio Inc (KALA)

Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kala Bio Inc 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 USA

www.kalarx.com P: 781-996-5252 F: 781-642-0399

Description:

KALA BIO is a clinical-stage biopharmaceutical company. It focused on the research, development and commercialization of therapies for rare and severe diseases of the eye. The company' s lead product candidate consists KPI-012. KALA BIO, formerly known as Kala Pharmaceuticals Inc., is based in ARLINGTON, Mass.

Key Statistics

Overview:

Market Capitalization, $K 19,941
Enterprise Value, $K 7,341
Shares Outstanding, K 2,816
Annual Sales, $ 0 K
Annual Net Income, $ -42,200 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -11,810 K
EBIT, $ -39,910 K
EBITDA, $ -38,350 K
60-Month Beta -2.04
% of Insider Shareholders 13.40%
% of Institutional Shareholders 24.61%
Float, K 2,439
% Float 86.60%
Short Volume Ratio 0.16

Growth:

1-Year Return -50.47%
3-Year Return -95.90%
5-Year Return -97.56%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 86.01%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -4.20 on 05/14/24
Next Earnings Date 08/02/24
Earnings Per Share ttm -15.15
EPS Growth vs. Prev Qtr -32.08%
EPS Growth vs. Prev Year 39.91%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 10/21/22

KALA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -366.43%
Return-on-Assets % -66.41%
Profit Margin % 0.00%
Debt/Equity 5.82
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.86
Book Value/Share 2.36
Interest Coverage -6.26
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar